PEBP1P2 and nonpapillary renal cell carcinoma: Moreover, ccRCC patients with low PEBP1P2 levels had shorter overall survival, progress-free interval, and disease-specific survival than papillary RCC and chromophobe RCC patients (Fig. 1g–i, Additional file 1: Fig. S2).